Bright Minds Biosciences Inc. (CSE:DRUG)
Canada
· Delayed Price · Currency is CAD 119.46
-2.08 (-1.71%)
Apr 28, 2026, 3:19 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 1.17 billion as of April 28, 2026. Its market cap has increased by 213.68% in one year.
Market Cap
1.17B
Enterprise Value
1.08B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
119.46
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 1.17B, an increase of 2,092.12%. That is a compound annual growth rate of 80.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.19B | 38.33% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 607.65M |
| Satellos Bioscience | 203.10M |
| Helix BioPharma | 148.94M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 63.16M |
| Sernova Biotherapeutics | 62.36M |
| NurExone Biologic | 54.31M |
| Medicenna Therapeutics | 54.22M |